vs
Natural Grocers by Vitamin Cottage, Inc.(NGVC)与Organogenesis Holdings Inc.(ORGO)财务数据对比。点击上方公司名可切换其他公司
Natural Grocers by Vitamin Cottage, Inc.的季度营收约是Organogenesis Holdings Inc.的9.0倍($335.6M vs $37.2M),Natural Grocers by Vitamin Cottage, Inc.同比增速更快(1.6% vs -57.1%),过去两年Natural Grocers by Vitamin Cottage, Inc.的营收复合增速更高(4.4% vs -46.5%)
Natural Grocers by Vitamin Cottage, Inc.是美国本土的特色零售连锁企业,主营认证有机食品、膳食补充剂、天然个护及环保家居类产品,面向健康意识较强的消费群体,门店覆盖美国多州,执行严格品控标准,拒绝售卖含人工添加剂的商品。
Organogenesis Holdings Inc.是一家领先的再生医学企业,专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品,主要服务美国及部分国际市场的医疗机构与患者,提供经临床验证的医疗解决方案。
NGVC vs ORGO — 直观对比
营收规模更大
NGVC
是对方的9.0倍
$37.2M
营收增速更快
NGVC
高出58.7%
-57.1%
两年增速更快
NGVC
近两年复合增速
-46.5%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $335.6M | $37.2M |
| 净利润 | $11.3M | — |
| 毛利率 | 29.5% | 30.8% |
| 营业利润率 | 4.4% | -185.1% |
| 净利率 | 3.4% | — |
| 营收同比 | 1.6% | -57.1% |
| 净利润同比 | 14.0% | — |
| 每股收益(稀释后) | $0.49 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
NGVC
ORGO
| Q1 26 | — | $37.2M | ||
| Q4 25 | $335.6M | $225.6M | ||
| Q3 25 | $336.1M | $150.9M | ||
| Q2 25 | $328.7M | $101.0M | ||
| Q1 25 | $335.8M | $86.7M | ||
| Q4 24 | $330.2M | $126.7M | ||
| Q3 24 | $322.7M | $115.2M | ||
| Q2 24 | $309.1M | $130.2M |
净利润
NGVC
ORGO
| Q1 26 | — | — | ||
| Q4 25 | $11.3M | $43.7M | ||
| Q3 25 | $11.8M | $21.6M | ||
| Q2 25 | $11.6M | $-9.4M | ||
| Q1 25 | $13.1M | $-18.8M | ||
| Q4 24 | $9.9M | $7.7M | ||
| Q3 24 | $9.0M | $12.3M | ||
| Q2 24 | $9.2M | $-17.0M |
毛利率
NGVC
ORGO
| Q1 26 | — | 30.8% | ||
| Q4 25 | 29.5% | — | ||
| Q3 25 | 29.5% | — | ||
| Q2 25 | 29.9% | — | ||
| Q1 25 | 30.3% | 72.6% | ||
| Q4 24 | 29.9% | 75.5% | ||
| Q3 24 | 29.6% | 76.7% | ||
| Q2 24 | 29.2% | 77.6% |
营业利润率
NGVC
ORGO
| Q1 26 | — | -185.1% | ||
| Q4 25 | 4.4% | 28.1% | ||
| Q3 25 | 4.6% | 13.7% | ||
| Q2 25 | 4.7% | -12.5% | ||
| Q1 25 | 5.2% | -30.9% | ||
| Q4 24 | 4.0% | 8.1% | ||
| Q3 24 | 3.7% | 5.4% | ||
| Q2 24 | 4.2% | -10.7% |
净利率
NGVC
ORGO
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | 19.4% | ||
| Q3 25 | 3.5% | 14.3% | ||
| Q2 25 | 3.5% | -9.3% | ||
| Q1 25 | 3.9% | -21.7% | ||
| Q4 24 | 3.0% | 6.1% | ||
| Q3 24 | 2.8% | 10.7% | ||
| Q2 24 | 3.0% | -13.1% |
每股收益(稀释后)
NGVC
ORGO
| Q1 26 | — | — | ||
| Q4 25 | $0.49 | $0.31 | ||
| Q3 25 | $0.51 | $0.11 | ||
| Q2 25 | $0.50 | $-0.10 | ||
| Q1 25 | $0.56 | $-0.17 | ||
| Q4 24 | $0.43 | $0.05 | ||
| Q3 24 | $0.38 | $0.09 | ||
| Q2 24 | $0.40 | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $23.2M | $91.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $220.0M | — |
| 总资产 | $668.6M | $520.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
NGVC
ORGO
| Q1 26 | — | $91.4M | ||
| Q4 25 | $23.2M | $93.7M | ||
| Q3 25 | $17.1M | $63.7M | ||
| Q2 25 | $13.2M | $73.1M | ||
| Q1 25 | $21.2M | $110.0M | ||
| Q4 24 | $6.3M | $135.6M | ||
| Q3 24 | $8.9M | $94.3M | ||
| Q2 24 | $13.9M | $89.9M |
总债务
NGVC
ORGO
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $62.3M | ||
| Q2 24 | — | $63.8M |
股东权益
NGVC
ORGO
| Q1 26 | — | — | ||
| Q4 25 | $220.0M | $300.1M | ||
| Q3 25 | $212.4M | $255.1M | ||
| Q2 25 | $202.5M | $233.2M | ||
| Q1 25 | $193.0M | $242.9M | ||
| Q4 24 | $181.9M | $262.9M | ||
| Q3 24 | $174.3M | $278.5M | ||
| Q2 24 | $167.8M | $263.5M |
总资产
NGVC
ORGO
| Q1 26 | — | $520.0M | ||
| Q4 25 | $668.6M | $598.7M | ||
| Q3 25 | $670.5M | $509.8M | ||
| Q2 25 | $659.0M | $461.1M | ||
| Q1 25 | $664.6M | $467.4M | ||
| Q4 24 | $648.9M | $497.9M | ||
| Q3 24 | $655.5M | $446.3M | ||
| Q2 24 | $654.4M | $443.2M |
负债/权益比
NGVC
ORGO
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.22× | ||
| Q2 24 | — | 0.24× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $21.1M | — |
| 自由现金流经营现金流 - 资本支出 | $11.6M | — |
| 自由现金流率自由现金流/营收 | 3.4% | — |
| 资本支出强度资本支出/营收 | 2.9% | — |
| 现金转化率经营现金流/净利润 | 1.86× | — |
| 过去12个月自由现金流最近4个季度 | $42.6M | — |
8季度趋势,按日历期对齐
经营现金流
NGVC
ORGO
| Q1 26 | — | — | ||
| Q4 25 | $21.1M | $39.4M | ||
| Q3 25 | $15.6M | $3.1M | ||
| Q2 25 | $2.9M | $-32.9M | ||
| Q1 25 | $34.1M | $-19.9M | ||
| Q4 24 | $2.7M | $10.9M | ||
| Q3 24 | $24.5M | $8.7M | ||
| Q2 24 | $12.4M | $4.7M |
自由现金流
NGVC
ORGO
| Q1 26 | — | — | ||
| Q4 25 | $11.6M | $34.8M | ||
| Q3 25 | $7.5M | $844.0K | ||
| Q2 25 | $-4.2M | $-36.5M | ||
| Q1 25 | $27.6M | $-23.6M | ||
| Q4 24 | $-6.9M | $7.6M | ||
| Q3 24 | $18.0M | $6.1M | ||
| Q2 24 | $3.6M | $2.9M |
自由现金流率
NGVC
ORGO
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | 15.4% | ||
| Q3 25 | 2.2% | 0.6% | ||
| Q2 25 | -1.3% | -36.1% | ||
| Q1 25 | 8.2% | -27.2% | ||
| Q4 24 | -2.1% | 6.0% | ||
| Q3 24 | 5.6% | 5.3% | ||
| Q2 24 | 1.2% | 2.2% |
资本支出强度
NGVC
ORGO
| Q1 26 | — | — | ||
| Q4 25 | 2.9% | 2.1% | ||
| Q3 25 | 2.4% | 1.5% | ||
| Q2 25 | 2.2% | 3.6% | ||
| Q1 25 | 1.9% | 4.2% | ||
| Q4 24 | 2.9% | 2.7% | ||
| Q3 24 | 2.0% | 2.2% | ||
| Q2 24 | 2.9% | 1.4% |
现金转化率
NGVC
ORGO
| Q1 26 | — | — | ||
| Q4 25 | 1.86× | 0.90× | ||
| Q3 25 | 1.32× | 0.14× | ||
| Q2 25 | 0.25× | — | ||
| Q1 25 | 2.60× | — | ||
| Q4 24 | 0.27× | 1.43× | ||
| Q3 24 | 2.72× | 0.71× | ||
| Q2 24 | 1.35× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NGVC
| Grocery | $243.8M | 73% |
| Dietary Supplements | $60.7M | 18% |
| Manufactured Product Other | $31.0M | 9% |
ORGO
暂无分部数据